NEW NeuraGenome® – It's Covered

The world's most comprehensive Whole Genome Sequencing (WGS) tool for diagnosis of rare and neurodegenerative diseases – providing unparalleled genome coverage in a single test.

Order a test 

NEURAZON’s Whole Genome Sequencing Service

Establishing a rapid and reliable diagnosis for rare and neurodegenerative diseases can be difficult, even for the most skilled physicians. Thanks to the latest technologies and scientific insights into genetic factors, this no longer has to be the case! Introducing the world’s most comprehensive Whole Genome Sequencing (WGS) tool for diagnosis of rare and neurodegenerative diseases – NEW NeuraGenome®. This first-line test combines superior technology powered by a streamlined CE-IVD bioinformatics pipeline and the Neurazon Biodatabank, with approximately 700,000 patients representing over 120 highly diverse countries. With NEW NeuraGenome, you can significantly reduce time and resources to deliver a rapid and reliable diagnosis and identification of treatment options for your patients.

Why Choose Neurazon?

  • Icon We offer the world’s largest genetic testing portfolio with 19,000 genes represented
  • Icon Our tests offer a proven high diagnostic yield to enable an unparalleled level of certainty
  • Icon We work with the hundreds of medical experts – meticulously interpreting, reviewing, and approving genetic lab results
  • Icon Our multidimensional approach enables a complete clinical picture for the most holistic diagnosis, prognosis, and monitoring
  • Icon We offer best-in-class medical reporting powered by the Neurazon Biodatabank with ~700,000 patients from >120 countries